BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21738597)

  • 1. Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy.
    Gasnault J; Costagliola D; Hendel-Chavez H; Dulioust A; Pakianather S; Mazet AA; de Goer de Herve MG; Lancar R; Lascaux AS; Porte L; Delfraissy JF; Taoufik Y;
    PLoS One; 2011; 6(6):e20967. PubMed ID: 21738597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and Prognostic Value of JC Virus DNA in Plasma in Progressive Multifocal Leukoencephalopathy.
    Ferretti F; Bestetti A; Yiannoutsos CT; Musick BS; Gerevini S; Passeri L; Bossolasco S; Boschini A; Franciotta D; Lazzarin A; Cinque P
    Clin Infect Dis; 2018 Jun; 67(1):65-72. PubMed ID: 29346632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive multifocal leukoencephalopathy in Zambia is caused by JC virus with prototype regulatory region.
    Mubanga E; Patel A; Siddiqi OK; Hanson BA; Dang X; Lakhi S; Mulundu G; Bender N; Koralnik IJ
    J Neurovirol; 2019 Aug; 25(4):475-479. PubMed ID: 31028690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy.
    Gasnault J; Kahraman M; de Goër de Herve MG; Durali D; Delfraissy JF; Taoufik Y
    AIDS; 2003 Jul; 17(10):1443-9. PubMed ID: 12824781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
    Bossolasco S; Calori G; Moretti F; Boschini A; Bertelli D; Mena M; Gerevini S; Bestetti A; Pedale R; Sala S; Sala S; Lazzarin A; Cinque P
    Clin Infect Dis; 2005 Mar; 40(5):738-44. PubMed ID: 15714422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity.
    Iannetta M; Bellizzi A; Lo Menzo S; Anzivino E; D'Abramo A; Oliva A; D'Agostino C; d'Ettorre G; Pietropaolo V; Vullo V; Ciardi MR
    J Neurovirol; 2013 Jun; 19(3):274-9. PubMed ID: 23715894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy.
    Koralnik IJ; Boden D; Mai VX; Lord CI; Letvin NL
    Neurology; 1999 Jan; 52(2):253-60. PubMed ID: 9932940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy.
    Gasnault J; Taoufik Y; Goujard C; Kousignian P; Abbed K; Boue F; Dussaix E; Delfraissy JF
    J Neurovirol; 1999 Aug; 5(4):421-9. PubMed ID: 10463864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Pembrolizumab for Treatment of Progressive Multifocal Leukoencephalopathy in People Living with HIV.
    Pinnetti C; Cimini E; Vergori A; Mazzotta V; Grassi G; Mondi A; Forbici F; Amendola A; Grisetti S; Baldini F; Candela C; Casetti R; Campioni P; Capobianchi MR; Agrati C; Antinori A
    Viruses; 2022 May; 14(5):. PubMed ID: 35632711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
    Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
    Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis.
    Marzocchetti A; Sanguinetti M; Giambenedetto SD; Cingolani A; Fadda G; Cauda R; De Luca A
    J Neurovirol; 2007 Aug; 13(4):338-46. PubMed ID: 17849317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response.
    Giudici B; Vaz B; Bossolasco S; Casari S; Brambilla AM; Lüke W; Lazzarin A; Weber T; Cinque P
    Clin Infect Dis; 2000 Jan; 30(1):95-9. PubMed ID: 10619739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semiquantitative detection of JCV-DNA in peripheral blood leukocytes from HIV-1-infected patients with or without progressive multifocal leukoencephalopathy.
    Andréoletti L; Lescieux A; Lambert V; Si-Mohamed A; Matta M; Wattré P; Bélec L
    J Med Virol; 2002 Jan; 66(1):1-7. PubMed ID: 11748651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.
    Lalezari JP; Henry K; O'Hearn M; Montaner JS; Piliero PJ; Trottier B; Walmsley S; Cohen C; Kuritzkes DR; Eron JJ; Chung J; DeMasi R; Donatacci L; Drobnes C; Delehanty J; Salgo M;
    N Engl J Med; 2003 May; 348(22):2175-85. PubMed ID: 12637625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring.
    Gasnault J; Kousignian P; Kahraman M; Rahoiljaon J; Matheron S; Delfraissy JF; Taoufik Y
    J Neurovirol; 2001 Aug; 7(4):375-81. PubMed ID: 11517420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: the clinical, neuroimaging, virological and evolutive characteristics in 35 patients].
    Asensi V; Cartón JA; Maradona JA; Oña M; Melón S; Martín-Roces ER; Asensi JM; Arribas JM
    Med Clin (Barc); 1999 Sep; 113(6):210-4. PubMed ID: 10472609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.
    Khanna N; Wolbers M; Mueller NJ; Garzoni C; Du Pasquier RA; Fux CA; Vernazza P; Bernasconi E; Viscidi R; Battegay M; Hirsch HH;
    J Virol; 2009 May; 83(9):4404-11. PubMed ID: 19211737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of survival in progressive multifocal leukoencephalopathy.
    Marzocchetti A; Tompkins T; Clifford DB; Gandhi RT; Kesari S; Berger JR; Simpson DM; Prosperi M; De Luca A; Koralnik IJ
    Neurology; 2009 Nov; 73(19):1551-8. PubMed ID: 19901246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Profile and Outcome of Progressive Multifocal Leukoencephalopathy in HIV Infected Indian Patients.
    Shah V; Toshniwal H; Shevkani M
    J Assoc Physicians India; 2017 Mar; 65(3):40-44. PubMed ID: 28462542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis.
    Wijburg MT; Kleerekooper I; Lissenberg-Witte BI; de Vos M; Warnke C; Uitdehaag BMJ; Barkhof F; Killestein J; Wattjes MP
    JAMA Neurol; 2018 Jul; 75(7):827-833. PubMed ID: 29532061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.